These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
224 related items for PubMed ID: 29288944
1. Biological evaluation of indolizine-chalcone hybrids as new anticancer agents. Park S, Kim EH, Kim J, Kim SH, Kim I. Eur J Med Chem; 2018 Jan 20; 144():435-443. PubMed ID: 29288944 [Abstract] [Full Text] [Related]
2. Synthesis, characterization and biological evaluation of anti-cancer indolizine derivatives via inhibiting β-catenin activity and activating p53. Moon SH, Jung Y, Kim SH, Kim I. Bioorg Med Chem Lett; 2016 Jan 01; 26(1):110-3. PubMed ID: 26608553 [Abstract] [Full Text] [Related]
3. Novel 1-(7-ethoxy-1-benzofuran-2-yl) substituted chalcone derivatives: Synthesis, characterization and anticancer activity. Coskun D, Erkisa M, Ulukaya E, Coskun MF, Ari F. Eur J Med Chem; 2017 Aug 18; 136():212-222. PubMed ID: 28494257 [Abstract] [Full Text] [Related]
4. Studies on indolizines. Evaluation of their biological properties as microtubule-interacting agents and as melanoma targeting compounds. Ghinet A, Abuhaie CM, Gautret P, Rigo B, Dubois J, Farce A, Belei D, Bîcu E. Eur J Med Chem; 2015 Jan 07; 89():115-27. PubMed ID: 25462232 [Abstract] [Full Text] [Related]
5. Discovery of indolizines containing triazine moiety as new leads for the development of antitumoral agents targeting mitotic events. Lucescu L, Ghinet A, Belei D, Rigo B, Dubois J, Bîcu E. Bioorg Med Chem Lett; 2015 Sep 15; 25(18):3975-9. PubMed ID: 26227778 [Abstract] [Full Text] [Related]
6. Design, synthesis, and evaluation of chalcone analogues incorporate α,β-Unsaturated ketone functionality as anti-lung cancer agents via evoking ROS to induce pyroptosis. Zhu M, Wang J, Xie J, Chen L, Wei X, Jiang X, Bao M, Qiu Y, Chen Q, Li W, Jiang C, Zhou X, Jiang L, Qiu P, Wu J. Eur J Med Chem; 2018 Sep 05; 157():1395-1405. PubMed ID: 30196062 [Abstract] [Full Text] [Related]
7. Synthesis and anti-proliferative activity of fluoro-substituted chalcones. Burmaoglu S, Algul O, Anıl DA, Gobek A, Duran GG, Ersan RH, Duran N. Bioorg Med Chem Lett; 2016 Jul 01; 26(13):3172-3176. PubMed ID: 27217001 [Abstract] [Full Text] [Related]
8. Novel anthraquinone based chalcone analogues containing an imine fragment: synthesis, cytotoxicity and anti-angiogenic activity. Kolundžija B, Marković V, Stanojković T, Joksović L, Matić I, Todorović N, Nikolić M, Joksović MD. Bioorg Med Chem Lett; 2014 Jan 01; 24(1):65-71. PubMed ID: 24332490 [Abstract] [Full Text] [Related]
9. Synthesis and evaluation of novel marine bromopyrrole alkaloid-based hybrids as anticancer agents. Rane RA, Sahu NU, Gutte SD, Mahajan AA, Shah CP, Bangalore P. Eur J Med Chem; 2013 May 01; 63():793-9. PubMed ID: 23584542 [Abstract] [Full Text] [Related]
10. New chalcone-type compounds and 2-pyrazoline derivatives: synthesis and caspase-dependent anticancer activity. Chouiter MI, Boulebd H, Pereira DM, Valentão P, Andrade PB, Belfaitah A, Silva AM. Future Med Chem; 2020 Mar 01; 12(6):493-509. PubMed ID: 32100558 [Abstract] [Full Text] [Related]
11. Synthesis and anti-cancer activity evaluation of novel prenylated and geranylated chalcone natural products and their analogs. Wang HM, Zhang L, Liu J, Yang ZL, Zhao HY, Yang Y, Shen D, Lu K, Fan ZC, Yao QW, Zhang YM, Teng YO, Peng Y. Eur J Med Chem; 2015 Mar 06; 92():439-48. PubMed ID: 25590864 [Abstract] [Full Text] [Related]
13. In vivo phase II-enzymes inducers, as potential chemopreventive agents, based on the chalcone and furoxan skeletons. Cabrera M, Mastandrea I, Otero G, Cerecetto H, González M. Bioorg Med Chem; 2016 Apr 15; 24(8):1665-74. PubMed ID: 26970663 [Abstract] [Full Text] [Related]
14. Synthesis and biological evaluation of novel synthetic chalcone derivatives as anti-tumor agents targeting Cat L and Cat K. Wang Y, Xue S, Li R, Zheng Z, Yi H, Li Z. Bioorg Med Chem; 2018 Jan 01; 26(1):8-16. PubMed ID: 29223717 [Abstract] [Full Text] [Related]
15. Indolizine-phenothiazine hybrids as the first dual inhibitors of tubulin polymerization and farnesyltransferase with synergistic antitumor activity. Moise IM, Bîcu E, Farce A, Dubois J, Ghinet A. Bioorg Chem; 2020 Oct 01; 103():104184. PubMed ID: 32891861 [Abstract] [Full Text] [Related]
16. In vitro and in vivo anti-glioma activity of a chalcone-quinoxaline hybrid. Loch-Neckel G, Bicca MA, Leal PC, Mascarello A, Siqueira JM, Calixto JB. Eur J Med Chem; 2015 Jan 27; 90():93-100. PubMed ID: 25461314 [Abstract] [Full Text] [Related]
17. Discovery of novel chalcone-dithiocarbamates as ROS-mediated apoptosis inducers by inhibiting catalase. Fu DJ, Li JH, Yang JJ, Li P, Zhang YB, Liu S, Li ZR, Zhang SY. Bioorg Chem; 2019 May 27; 86():375-385. PubMed ID: 30763884 [Abstract] [Full Text] [Related]
18. Synthesis and bio-evaluation of indole-chalcone based benzopyrans as promising antiligase and antiproliferative agents. Gupta S, Maurya P, Upadhyay A, Kushwaha P, Krishna S, Siddiqi MI, Sashidhara KV, Banerjee D. Eur J Med Chem; 2018 Jan 01; 143():1981-1996. PubMed ID: 29146133 [Abstract] [Full Text] [Related]
19. Chalcone-benzoxaborole hybrids as novel anticancer agents. Zhang J, Yang F, Qiao Z, Zhu M, Zhou H. Bioorg Med Chem Lett; 2016 Dec 01; 26(23):5797-5801. PubMed ID: 28327308 [Abstract] [Full Text] [Related]
20. Chalcone derivatives targeting mitosis: synthesis, evaluation of antitumor activity and lipophilicity. Pinto P, Machado CM, Moreira J, Almeida JDP, Silva PMA, Henriques AC, Soares JX, Salvador JAR, Afonso C, Pinto M, Bousbaa H, Cidade H. Eur J Med Chem; 2019 Dec 15; 184():111752. PubMed ID: 31610374 [Abstract] [Full Text] [Related] Page: [Next] [New Search]